Purpose Of Review: To discuss the recent insights into the relationships between viral respiratory infections and asthma inception in the context of a long-term goal of moving toward prevention strategies for childhood asthma.
Recent Findings: There is strong evidence for respiratory syncytial virus and human rhinovirus wheezing illnesses as important risk factors for asthma inception. The mechanisms underlying these relationships have been an intense area of study. Novel approaches for the prevention of virus infections and/or lessening the severity of associated illnesses are at various stages of development, and are important potential tools in efforts aimed at primary and secondary prevention of asthma.
Summary: Viral respiratory infections in early life are a major source of morbidity and are critical in the development of asthma. Mechanisms by which these infections lead to asthma inception in susceptible individuals are emerging. Further, there are promising potential interventions currently available that should be tested in clinical trials. The goal of prevention of disease inception is clearly on the horizon.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083742 | PMC |
| http://dx.doi.org/10.1097/ACI.0000000000000047 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID-19 Pandemic.
Pediatr Pulmonol
January 2025
The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Background: Respiratory syncytial virus (RSV) infection in the first year of life has been linked with an increased risk for asthma. Some propose that RSV-induced inflammation leads to lasting airway changes, while others contend that RSV bronchiolitis is a marker for underlying predisposition. Social distancing adopted during the COVID-19 pandemic has led to a dramatic reduction in RSV activity, providing an unexpected opportunity to investigate this debate.
View Article and Find Full Text PDFEpidemiology of asthma across the ages.
Ann Allergy Asthma Immunol
December 2024
Allergy Department, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece; Lydia Becker Institute, University of Manchester, Manchester, UK. Electronic address:
In the last three decades, the overall prevalence of asthma appears to be plateauing, although large geographical and socioeconomic variation is evident. Overall, asthma prevalence slightly decreased in most age groups, except for school-aged children. Of note, asthma mortality steadily decreased, potentially highlighting improved asthma management strategies.
View Article and Find Full Text PDFAmbient air pollution exposure and adult asthma incidence: a systematic review and meta-analysis.
Lancet Planet Health
December 2024
Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada; Legacy for Airway Health, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada. Electronic address:
Background: Ambient (outdoor) air pollutant exposures have emerged as a plausible risk factor for incident childhood asthma. However, the effect of ambient air pollutant exposures on risk of incident adult asthma is unclear. We aimed to investigate associations between specific ambient air pollutants and the risk of incident adult asthma.
View Article and Find Full Text PDFPostacute Sequelae of COVID-19 in Pediatric Patients Within the United States: A Scoping Review.
Am J Med Open
December 2024
Department of Immunobiology, Yale School of Medicine, New Haven, CT.
A subset of children and adolescents experience recurrent or persistent symptoms following SARS-CoV-2 infection, known as postacute sequelae of COVID-19 (PASC), however, the clinical epidemiology within the United States (US) is not yet well understood. This scoping review aims to synthesize the clinical epidemiology of pediatric PASC in the US. A comprehensive literature search was conducted and databases were queried from inception until January 29, 2024.
View Article and Find Full Text PDFMast Cells and Mas-related G Protein-coupled Receptor X2: Itching for Novel Pathophysiological Insights to Clinical Relevance.
Curr Allergy Asthma Rep
November 2024
Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Building 2, Room C10, 6439 Garners Ferry Road, Columbia, SC, 29209, USA.
Article Synopsis
- The review highlights the significance of the MRGPRX2 receptor in non-IgE mast cell activation, linking it to various allergic and inflammatory conditions like asthma and drug hypersensitivity.
- Recent findings indicate that certain MRGPRX2 agonists can cause anaphylaxis in patients, suggesting variability in responses among individuals.
- The paper discusses advancements in understanding the receptor's structure, expression, and signaling, while also exploring possible therapeutic agents that could modulate its activity.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!